ArticleCancer research2018
Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.
Abstract readConference Proceedings
In one paragraph
Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- C. Norman Coleman's Legacy in Radiation Research and Global Health: A Cancer Research and Care Perspective.Disaster medicine and public health preparedness · 2026Article
- Machine learning modeling of cancer treatment-related cardiac events in breast cancer: utilizing dosiomics and radiomics.Frontiers in oncology · 2025Article
- Harnessing Senescence for Antitumor Immunity to Advance Cancer Treatment.Radiation research · 2024Article
- Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.The Lancet. Oncology · 2024Review
- Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022Article
- Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community.Radiation research · 2022Article
- Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021Article
- Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.Journal of the National Cancer Institute · 2021Article
- Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.International journal of radiation oncology, biology, physics · 2021Review
- Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care.JNCI cancer spectrum · 2021Article
- Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?Journal for immunotherapy of cancer · 2021Review
- Radiation-induced Adaptive Response: New Potential for Cancer Treatment.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020Review
- Enhancing Career Paths for Tomorrow's Radiation Oncologists.International journal of radiation oncology, biology, physics · 2019Review
- Monte Carlo Processing on a Chip (MCoaC)-preliminary experiments toward the realization of optimal-hardware for TOPAS/Geant4 to drive discovery.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2019Article
- Article
- The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: Advancements Symposium and Subsequent Progress Made.Practical radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Mansoor M Ahmed *Radiation Research Program, National Cancer Institute, Bethesda, Maryland. ccoleman@mail.nih.gov ahmedmm@mail.nih.gov.
C Norman Coleman *Radiation Research Program, National Cancer Institute, Bethesda, Maryland. ccoleman@mail.nih.gov ahmedmm@mail.nih.gov.
Marc MendoncaDepartment of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
Soren BentzenDepartment of Epidemiology, University of Maryland School of Medicine, Baltimore, Maryland.
Bhadrasain VikramRadiation Research Program, National Cancer Institute, Bethesda, Maryland.
Stephen M SeltzerRadiation Physics Division, NIST, Gaithersburg, Maryland.
Dudley GoodheadMedical Research Council, Harwell, Didcot, United Kingdom.
Ceferino ObcemeaRadiation Research Program, National Cancer Institute, Bethesda, Maryland.
Radhe MohanDivision of Radiation Oncology, Department of Radiation Physics, The University of Texas, MD Anderson Cancer Centre, Houston, Texas.
Kevin M PriseCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Jacek CapalaRadiation Research Program, National Cancer Institute, Bethesda, Maryland.
Deborah CitrinRadiation Oncology Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Gary KaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Molykutty AryankalayilRadiation Oncology Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Iris EkeRadiation Oncology Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Jeffrey C BuchsbaumRadiation Research Program, National Cancer Institute, Bethesda, Maryland.
Pataje G S PrasannaRadiation Research Program, National Cancer Institute, Bethesda, Maryland.
Fei-Fei LiuDepartment of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Canada.
Quynh-Thu LeDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Beverly TeicherDevelopment Therapeutics Program, National Cancer Institute, Bethesda, Maryland.
David G KirschDepartment of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina.
DeeDee SmartRadiation Oncology Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Joel TepperDepartment of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Silvia FormentiDepartment of Radiation Oncology, Weill Cornell Medical College, New York City, New York.
Daphne Haas-KoganDepartment of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts.
David RabenDepartment of Radiation Oncology; University of Colorado Cancer Center, Aurora, Colorado.
James MitchellRadiation Biology Branch, National Cancer Institute, Bethesda, Maryland.
Funding
Mechanisms of Normal Tissue Toxicity From IrradiationZIABC010850 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CITRIN, DEBORAH · 2009 to 2025
$19.4MRadiation-induced molecular targetsZIABC010670 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COLEMAN, NORMAN · 2009 to 2024
$17.3MTargeting mechanisms of radiation resistanceZIABC011552 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CITRIN, DEBORAH · 2014 to 2025
$12.2MMechanisms of Normal Tissue ToxicityZ01BC010850 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CITRIN, DEBORAH · 2007 to 2008
$1.0MIntramural NIH HHS Z01 BC010850Intramural NIH HHS Z99 CA999999
Abstract
PubMed holds no abstract for this paper.
Indexed as
HumansNeoplasmsRadiotherapyRadiotherapy DosageRadiotherapy Planning, Computer-Assisted
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.